天新药业：29071.48万股限售股1月12日解禁

Core Viewpoint - Tianxin Pharmaceutical announced the upcoming circulation of restricted shares, totaling 29,071.48 million shares, which represents 66.41% of the company's total share capital [1] Group 1: Share Circulation Details - The circulation date for the restricted shares is set for January 12, 2026 [1] - The restricted shares are part of the company's initial public offering and involve shareholders such as Xu Jiangnan, Xu Jing, and several investment management partnerships [1] - Following the circulation of these restricted shares, the number of restricted circulating shares will decrease by 29,071.48 million, while the number of unrestricted circulating shares will increase correspondingly [1]